A Double-Blind, Double-Dummy, Randomized, Multicenter Study Comparing The Analgesic Efficacy And Safety Of Parecoxib 40mg I.V. To Ketoprofen 100mg I.V. In Renal Colic.

Trial Profile

A Double-Blind, Double-Dummy, Randomized, Multicenter Study Comparing The Analgesic Efficacy And Safety Of Parecoxib 40mg I.V. To Ketoprofen 100mg I.V. In Renal Colic.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Jan 2013

At a glance

  • Drugs Parecoxib (Primary) ; Ketoprofen
  • Indications Renal colic
  • Focus Therapeutic Use
  • Acronyms NAP
  • Sponsors Pfizer
  • Most Recent Events

    • 08 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 May 2009 Planned end date changed from Apr 2009 to Jun 2009 as reported by ClinicalTrials.gov.
    • 22 Jan 2009 Acronym identified as NAP as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top